Cargando…
Third Cranial Nerve Palsy after Monoclonal Antibody Therapy for Lung Cancer: A Case Report
Immune checkpoint inhibitors (ICIs) have shown promise in treating cancer patients, and pembrolizumab is a monoclonal IgG4 antibody that targets a human cell surface protein (receptor) called PD-1. Among the side effects, a rare cranial nerve palsy unrelated to the surgical treatment may occur. We r...
Autores principales: | Missori, Paolo, Ambrosone, Angela, Cristofani, Leonardo, Fattapposta, Francesco, Currà, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149351/ https://www.ncbi.nlm.nih.gov/pubmed/35702522 http://dx.doi.org/10.1159/000524114 |
Ejemplares similares
-
Surgical Treatment of Single Pontomedullary Junction Metastasis from Lung Cancer
por: Missori, Paolo, et al.
Publicado: (2022) -
Third cranial nerve palsy and posterior communicating artery aneurysm
por: Kim, Joon-young, et al.
Publicado: (2014) -
Third Cranial Nerve Palsy Due to COVID-19 Infection
por: Douedi, Steven, et al.
Publicado: (2021) -
Third cranial nerve palsy due to COVID-19 infection
por: Iwasaki, Monika, et al.
Publicado: (2023) -
Balance Dysfunction in Parkinson's Disease
por: Rinalduzzi, Steno, et al.
Publicado: (2015)